Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Timken (TKR) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Timken (TKR) over the last 17 years, with Q4 2025 value amounting to $364.4 million.

  • Timken's Cash & Equivalents fell 235.8% to $364.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $364.4 million, marking a year-over-year decrease of 235.8%. This contributed to the annual value of $364.4 million for FY2025, which is 235.8% down from last year.
  • According to the latest figures from Q4 2025, Timken's Cash & Equivalents is $364.4 million, which was down 235.8% from $449.1 million recorded in Q3 2025.
  • Over the past 5 years, Timken's Cash & Equivalents peaked at $469.9 million during Q2 2024, and registered a low of $257.1 million during Q4 2021.
  • For the 5-year period, Timken's Cash & Equivalents averaged around $361.9 million, with its median value being $366.2 million (2023).
  • In the last 5 years, Timken's Cash & Equivalents crashed by 2649.18% in 2021 and then soared by 4042.34% in 2022.
  • Quarter analysis of 5 years shows Timken's Cash & Equivalents stood at $257.1 million in 2021, then grew by 28.98% to $331.6 million in 2022, then grew by 26.33% to $418.9 million in 2023, then decreased by 10.91% to $373.2 million in 2024, then fell by 2.36% to $364.4 million in 2025.
  • Its Cash & Equivalents stands at $364.4 million for Q4 2025, versus $449.1 million for Q3 2025 and $419.3 million for Q2 2025.